Skip to main content

HOLLENCREST CAPITAL MANAGEMENT

Position in JNJ — Johnson & Johnson

CIK 1161722 NEWPORT BEACH, CA

Position in JNJ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,268,072
-$2,448,393 QoQ
Shares Held
4,993
-67.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,763
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Jun 30, 2026
CallValue
$101,588
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

HOLLENCREST CAPITAL MANAGEMENT holds $5,976,653 across 13 Drug Manufacturers - General names. JNJ ranks #3 (21.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 JNJ
Johnson & Johnson
This page
4,993 $1,268,072

All Filings in JNJ

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,268,072 4,993
2026-06-30 $101,588 400
2026-03-31 $3,716,465 15,204
2025-12-31 $1,300,266 6,283
2025-09-30 $1,183,535 6,383
2025-06-30 $974,850 6,382
2025-03-31 $1,173,152 7,074
2024-12-31 $1,030,272 7,124
2024-09-30 $1,177,041 7,263
2024-06-30 $1,082,753 7,408
2024-03-31 $1,620,972 10,247
2023-12-31 $1,645,456 10,498
2023-09-30 $1,987,993 12,764
2023-06-30 $2,201,747 13,302
2023-03-31 $2,187,825 14,115
2022-12-31 $2,144,884 12,142
2022-09-30 $1,970,448 12,062
2022-06-30 $2,166,686 12,206
2022-03-31 $2,198,537 12,405
2021-12-31 $2,124,688 12,420
2021-09-30 $1,995,332 12,355
2021-06-30 $1,661,896 10,088
2021-03-31 $2,078,369 12,646
2020-12-31 $1,754,786 11,150
2020-09-30 $1,637,679 11,000
2020-06-30 $1,549,038 11,015
2020-03-31 $1,359,424 10,367